Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary mediastinal large B-cell lymphoma.

Jason E Faris1, Ann S LaCasce

  • 1Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, 02115, USA.

Clinical Advances in Hematology & Oncology : H&O
|April 16, 2009
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

Primary Lymphoid Organs01:16

Primary Lymphoid Organs

Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
Secondary Lymphoid Organs01:15

Secondary Lymphoid Organs

Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rethinking Cardiovascular Events, End Points, and Surveillance in Oncology Trials.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Ipilimumab with and without nivolumab in patients with classic Hodgkin lymphoma with progression after PD-1 blockade.

Blood neoplasia·2025
Same author

Consensus recommendations from the 2024 International Follicular Lymphoma Scientific Workshop.

Blood advances·2025
Same author

A retrospective study of treatment and outcomes in synchronous systemic and central nervous system large B-cell lymphoma.

Blood advances·2025
Same author

NCCN Guidelines® Insights: B-Cell Lymphomas 3.2025.

Journal of the National Comprehensive Cancer Network : JNCCN·2025
Same author

Cardiovascular and Oncologic Considerations in Adult Hodgkin Lymphoma: JACC: CardioOncology State-of the-Art Review.

JACC. CardioOncology·2025
Same journal

Clinical response with cabozantinib plus nivolumab, a first-line therapy in advanced renal cell carcinoma: a clinical case report.

Clinical advances in hematology & oncology : H&O·2026
Same journal

Active treatment in high-risk, early-stage CLL or SLL.

Clinical advances in hematology & oncology : H&O·2026
Same journal

Targeting human kallikrein 2 in prostate cancer.

Clinical advances in hematology & oncology : H&O·2026
Same journal

Targeting BRAF V600E mutations in metastatic colorectal cancer.

Clinical advances in hematology & oncology : H&O·2026
Same journal

The development of second-generation KRAS inhibitors.

Clinical advances in hematology & oncology : H&O·2026
Same journal

Clinical applications of PARP inhibitors in breast, ovarian, and prostate cancer: current insights and future directions.

Clinical advances in hematology & oncology : H&O·2026
See all related articles

Primary mediastinal large B-cell lymphoma (PMBCL) treatment is primarily anthracycline-based chemotherapy. This review examines controversial aspects of PMBCL management, including newer regimens, radiotherapy, and response assessment.

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • Primary mediastinal large B-cell lymphoma (PMBCL) is a distinct subtype of diffuse large B-cell lymphoma.
  • PMBCL shares clinical and molecular features with nodular sclerosing/classical Hodgkin lymphoma.
  • Anthracycline-based chemotherapy is the standard treatment for PMBCL.

Purpose of the Study:

  • To review controversial topics in the management of PMBCL.
  • To highlight areas requiring further research in PMBCL treatment.
  • To discuss the efficacy of different therapeutic strategies and response assessment methods.

Main Methods:

  • Literature review of controversial topics in PMBCL treatment.
  • Discussion of comparative efficacy of chemotherapy regimens.

Related Experiment Videos

  • Analysis of radiotherapy use and positron emission tomography (PET) scan interpretation.

    • Main Results:

    • The superiority of third-generation regimens over CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) is debated.
    • The role and extent of involved field radiotherapy in PMBCL treatment remain controversial.
    • The optimal method for assessing clinical response using PET scans requires further investigation.

    Conclusions:

    • Further research is needed to clarify the optimal treatment strategies for PMBCL.
    • Comparative studies are essential to determine the best chemotherapy regimens.
    • Standardization of radiotherapy techniques and PET response assessment criteria is warranted.